Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | MIA2 | Human | (+)-catechin | multiple interactions | EXP | | 6480464 | [Catechin co-treated with Grape Seed Proanthocyanidins] results in decreased expression of MIA2 mRNA | CTD | PMID:24763279 | MIA2 | Human | (1->4)-beta-D-glucan | multiple interactions | ISO | Mia2 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of MIA2 mRNA | CTD | PMID:36331819 | MIA2 | Human | 1,2-dichloroethane | decreases expression | ISO | Mia2 (Mus musculus) | 6480464 | ethylene dichloride results in decreased expression of MIA2 mRNA | CTD | PMID:28960355 | MIA2 | Human | 1,2-dimethylhydrazine | multiple interactions | ISO | Mia2 (Mus musculus) | 6480464 | [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of MIA2 mRNA | CTD | PMID:22206623 | MIA2 | Human | 1,2-dimethylhydrazine | increases expression | ISO | Mia2 (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine results in increased expression of MIA2 mRNA | CTD | PMID:22206623 | MIA2 | Human | 17alpha-ethynylestradiol | multiple interactions | ISO | Mia2 (Mus musculus) | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of MIA2 mRNA | CTD | PMID:17942748 | MIA2 | Human | 17beta-estradiol | decreases expression | ISO | Mia2 (Rattus norvegicus) | 6480464 | Estradiol results in decreased expression of MIA2 mRNA | CTD | PMID:32145629 | MIA2 | Human | 17beta-estradiol | affects expression | ISO | Mia2 (Rattus norvegicus) | 6480464 | Estradiol affects the expression of MIA2 mRNA | CTD | PMID:32145629 | MIA2 | Human | 2,2',4,4',5,5'-hexachlorobiphenyl | multiple interactions | ISO | Mia2 (Mus musculus) | 6480464 | [Tetrachlorodibenzodioxin co-treated with 2 more ... | CTD | PMID:28433925 | MIA2 | Human | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | Mia2 (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of MIA2 mRNA | CTD | PMID:21215274 | MIA2 | Human | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | Mia2 (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of MIA2 mRNA | CTD | PMID:33387578 | MIA2 | Human | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | Mia2 (Mus musculus) | 6480464 | [Tetrachlorodibenzodioxin co-treated with 2 more ... | CTD | PMID:17942748 and PMID:28433925 | MIA2 | Human | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of MIA2 mRNA | CTD | PMID:20106945 and PMID:21632981 | MIA2 | Human | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Mia2 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of MIA2 mRNA | CTD | PMID:21570461 and PMID:26377647 | MIA2 | Human | 2,3,7,8-Tetrachlorodibenzofuran | increases expression | ISO | Mia2 (Rattus norvegicus) | 6480464 | 2 more ... | CTD | PMID:32109520 | MIA2 | Human | 3,3',4,4'-tetrachlorobiphenyl | multiple interactions | ISO | Mia2 (Mus musculus) | 6480464 | 3 more ... | CTD | PMID:19467301 | MIA2 | Human | 3,4-methylenedioxymethamphetamine | decreases expression | ISO | Mia2 (Mus musculus) | 6480464 | N-Methyl-3 and 4-methylenedioxyamphetamine results in decreased expression of MIA2 mRNA | CTD | PMID:26251327 | MIA2 | Human | 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | EXP | | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of MIA2 mRNA | CTD | PMID:28628672 | MIA2 | Human | 4,4'-diaminodiphenylmethane | increases expression | ISO | Mia2 (Mus musculus) | 6480464 | 4 and 4'-diaminodiphenylmethane results in increased expression of MIA2 mRNA | CTD | PMID:18648102 | MIA2 | Human | 4,4'-sulfonyldiphenol | affects methylation | ISO | Mia2 (Mus musculus) | 6480464 | bisphenol S affects the methylation of MIA2 gene | CTD | PMID:31683443 | MIA2 | Human | 8-Br-cAMP | decreases expression | EXP | | 6480464 | 8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of MIA2 mRNA | CTD | PMID:22079614 | MIA2 | Human | aflatoxin B1 | decreases expression | EXP | | 6480464 | Aflatoxin B1 results in decreased expression of MIA2 mRNA | CTD | PMID:22100608 | MIA2 | Human | aflatoxin B1 | decreases methylation | EXP | | 6480464 | Aflatoxin B1 results in decreased methylation of MIA2 gene | CTD | PMID:27153756 | MIA2 | Human | aflatoxin B1 | affects expression | EXP | | 6480464 | Aflatoxin B1 affects the expression of MIA2 protein | CTD | PMID:20106945 | MIA2 | Human | aristolochic acid A | decreases expression | EXP | | 6480464 | aristolochic acid I results in decreased expression of MIA2 mRNA | CTD | PMID:33212167 | MIA2 | Human | Aroclor 1254 | decreases expression | ISO | Mia2 (Mus musculus) | 6480464 | Chlorodiphenyl (54% Chlorine) results in decreased expression of MIA2 mRNA | CTD | PMID:23650126 | MIA2 | Human | bis(2-ethylhexyl) phthalate | multiple interactions | ISO | Mia2 (Mus musculus) | 6480464 | [Tetrachlorodibenzodioxin co-treated with 2 more ... | CTD | PMID:28433925 | MIA2 | Human | bisphenol A | affects expression | ISO | Mia2 (Rattus norvegicus) | 6480464 | bisphenol A affects the expression of MIA2 mRNA | CTD | PMID:30816183 and PMID:32145629 | MIA2 | Human | bisphenol A | affects expression | EXP | | 6480464 | bisphenol A affects the expression of MIA2 mRNA | CTD | PMID:30903817 | MIA2 | Human | bisphenol A | decreases expression | ISO | Mia2 (Mus musculus) | 6480464 | bisphenol A results in decreased expression of MIA2 mRNA | CTD | PMID:33221593 | MIA2 | Human | bisphenol A | decreases expression | ISO | Mia2 (Rattus norvegicus) | 6480464 | bisphenol A results in decreased expression of MIA2 mRNA | CTD | PMID:32145629 | MIA2 | Human | bisphenol A | multiple interactions | ISO | Mia2 (Mus musculus) | 6480464 | [Tetrachlorodibenzodioxin co-treated with 2 more ... | CTD | PMID:28433925 | MIA2 | Human | bisphenol A | multiple interactions | EXP | | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of MIA2 mRNA | CTD | PMID:28628672 | MIA2 | Human | butanal | decreases expression | EXP | | 6480464 | butyraldehyde results in decreased expression of MIA2 mRNA | CTD | PMID:26079696 | MIA2 | Human | caffeine | increases phosphorylation | EXP | | 6480464 | Caffeine results in increased phosphorylation of MIA2 protein | CTD | PMID:35688186 | MIA2 | Human | carbon nanotube | decreases expression | ISO | Mia2 (Mus musculus) | 6480464 | Nanotubes and Carbon results in decreased expression of MIA2 mRNA | CTD | PMID:25620056 | MIA2 | Human | CGP 52608 | multiple interactions | EXP | | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to MIA2 gene] | CTD | PMID:28238834 | MIA2 | Human | cholesterol | multiple interactions | ISO | Mia2 (Mus musculus) | 6480464 | [Cholesterol co-treated with 1 and 2-dioleoyloxy-3-(trimethylammonium)propane] results in increased expression of MIA2 mRNA | CTD | PMID:22129739 | MIA2 | Human | choline | multiple interactions | ISO | Mia2 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of MIA2 mRNA | CTD | PMID:20938992 | MIA2 | Human | chromium(6+) | affects expression | ISO | Mia2 (Mus musculus) | 6480464 | chromium hexavalent ion affects the expression of MIA2 mRNA | CTD | PMID:28472532 | MIA2 | Human | clorgyline | increases expression | EXP | | 6480464 | Clorgyline results in increased expression of MIA2 mRNA | CTD | PMID:19691856 | MIA2 | Human | cobalt dichloride | increases expression | EXP | | 6480464 | cobaltous chloride results in increased expression of MIA2 mRNA | CTD | PMID:19376846 | MIA2 | Human | copper atom | multiple interactions | EXP | | 6480464 | [NSC 689534 binds to Copper] which results in increased expression of MIA2 mRNA | CTD | PMID:20971185 | MIA2 | Human | copper atom | multiple interactions | ISO | Mia2 (Mus musculus) | 6480464 | [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of MIA2 mRNA | CTD | PMID:15467011 | MIA2 | Human | copper(0) | multiple interactions | EXP | | 6480464 | [NSC 689534 binds to Copper] which results in increased expression of MIA2 mRNA | CTD | PMID:20971185 | MIA2 | Human | copper(0) | multiple interactions | ISO | Mia2 (Mus musculus) | 6480464 | [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of MIA2 mRNA | CTD | PMID:15467011 | MIA2 | Human | copper(II) sulfate | increases expression | EXP | | 6480464 | Copper Sulfate results in increased expression of MIA2 mRNA | CTD | PMID:19549813 | MIA2 | Human | coumarin | decreases phosphorylation | EXP | | 6480464 | coumarin results in decreased phosphorylation of MIA2 protein | CTD | PMID:35688186 | MIA2 | Human | cyclosporin A | decreases expression | EXP | | 6480464 | Cyclosporine results in decreased expression of MIA2 mRNA | CTD | PMID:20106945 and PMID:25562108 | MIA2 | Human | cyclosporin A | affects expression | EXP | | 6480464 | Cyclosporine affects the expression of MIA2 mRNA | CTD | PMID:27989131 | MIA2 | Human | cyclosporin A | increases expression | EXP | | 6480464 | Cyclosporine results in increased expression of MIA2 mRNA | CTD | PMID:25562108 | MIA2 | Human | dexamethasone | multiple interactions | EXP | | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of MIA2 mRNA | CTD | PMID:28628672 | MIA2 | Human | dicrotophos | decreases expression | EXP | | 6480464 | dicrotophos results in decreased expression of MIA2 mRNA | CTD | PMID:28302478 | MIA2 | Human | epoxiconazole | decreases expression | ISO | Mia2 (Mus musculus) | 6480464 | epoxiconazole results in decreased expression of MIA2 mRNA | CTD | PMID:35436446 | MIA2 | Human | fipronil | increases expression | ISO | Mia2 (Rattus norvegicus) | 6480464 | fipronil results in increased expression of MIA2 mRNA | CTD | PMID:23962444 | MIA2 | Human | fluoranthene | multiple interactions | ISO | Mia2 (Mus musculus) | 6480464 | [1-methylanthracene co-treated with fluoranthene] results in increased expression of MIA2 mRNA | CTD | PMID:28329830 | MIA2 | Human | flutamide | decreases expression | ISO | Mia2 (Rattus norvegicus) | 6480464 | Flutamide results in decreased expression of MIA2 mRNA | CTD | PMID:24793618 | MIA2 | Human | folic acid | multiple interactions | ISO | Mia2 (Mus musculus) | 6480464 | [1 more ... | CTD | PMID:20938992 and PMID:22206623 | MIA2 | Human | gentamycin | increases expression | ISO | Mia2 (Rattus norvegicus) | 6480464 | Gentamicins results in increased expression of MIA2 mRNA | CTD | PMID:22061828 | MIA2 | Human | glycidyl methacrylate | decreases expression | EXP | | 6480464 | glycidyl methacrylate results in decreased expression of MIA2 protein | CTD | PMID:36641056 | MIA2 | Human | hydrogen peroxide | increases expression | EXP | | 6480464 | Hydrogen Peroxide results in increased expression of MIA2 mRNA | CTD | PMID:12414654 | MIA2 | Human | indometacin | multiple interactions | EXP | | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of MIA2 mRNA | CTD | PMID:28628672 | MIA2 | Human | L-methionine | multiple interactions | ISO | Mia2 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of MIA2 mRNA | CTD | PMID:20938992 | MIA2 | Human | lead diacetate | decreases expression | ISO | Mia2 (Mus musculus) | 6480464 | lead acetate results in decreased expression of MIA2 mRNA | CTD | PMID:21829687 | MIA2 | Human | leflunomide | increases expression | EXP | | 6480464 | leflunomide results in increased expression of MIA2 mRNA | CTD | PMID:28988120 | MIA2 | Human | menadione | increases expression | EXP | | 6480464 | Vitamin K 3 results in increased expression of MIA2 mRNA | CTD | PMID:12414654 | MIA2 | Human | methamphetamine | decreases expression | ISO | Mia2 (Mus musculus) | 6480464 | Methamphetamine results in decreased expression of MIA2 mRNA | CTD | PMID:26307267 | MIA2 | Human | methidathion | decreases expression | ISO | Mia2 (Mus musculus) | 6480464 | methidathion results in decreased expression of MIA2 mRNA | CTD | PMID:34813904 | MIA2 | Human | oxaliplatin | multiple interactions | ISO | Mia2 (Rattus norvegicus) | 6480464 | [Oxaliplatin co-treated with Topotecan] results in decreased expression of MIA2 mRNA | CTD | PMID:25729387 | MIA2 | Human | p-toluidine | increases expression | ISO | Mia2 (Rattus norvegicus) | 6480464 | 4-toluidine results in increased expression of MIA2 mRNA | CTD | PMID:27638505 | MIA2 | Human | paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of MIA2 mRNA | CTD | PMID:26690555 | MIA2 | Human | paracetamol | increases expression | ISO | Mia2 (Rattus norvegicus) | 6480464 | Acetaminophen results in increased expression of MIA2 mRNA | CTD | PMID:33387578 | MIA2 | Human | paraquat | decreases expression | ISO | Mia2 (Mus musculus) | 6480464 | Paraquat results in decreased expression of MIA2 mRNA | CTD | PMID:21371552 | MIA2 | Human | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | Mia2 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of MIA2 mRNA | CTD | PMID:36331819 | MIA2 | Human | pirinixic acid | multiple interactions | ISO | Mia2 (Mus musculus) | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of MIA2 mRNA | CTD | PMID:19710929 | MIA2 | Human | quercetin | decreases expression | EXP | | 6480464 | Quercetin results in decreased expression of MIA2 mRNA | CTD | PMID:21632981 | MIA2 | Human | resveratrol | multiple interactions | EXP | | 6480464 | [Plant Extracts co-treated with Resveratrol] results in increased expression of MIA2 mRNA | CTD | PMID:23557933 | MIA2 | Human | rotenone | increases expression | ISO | Mia2 (Rattus norvegicus) | 6480464 | Rotenone results in increased expression of MIA2 mRNA | CTD | PMID:19013527 | MIA2 | Human | silicon dioxide | decreases expression | EXP | | 6480464 | Silicon Dioxide analog results in decreased expression of MIA2 mRNA | CTD | PMID:25895662 | MIA2 | Human | sodium arsenite | decreases expression | EXP | | 6480464 | sodium arsenite results in decreased expression of MIA2 mRNA | CTD | PMID:28595984 more ... | MIA2 | Human | sodium fluoride | increases expression | ISO | Mia2 (Mus musculus) | 6480464 | Sodium Fluoride results in increased expression of MIA2 protein | CTD | PMID:28918527 | MIA2 | Human | sulforaphane | increases expression | EXP | | 6480464 | sulforaphane results in increased expression of MIA2 mRNA | CTD | PMID:31838189 | MIA2 | Human | sunitinib | increases expression | EXP | | 6480464 | Sunitinib results in increased expression of MIA2 mRNA | CTD | PMID:31533062 | MIA2 | Human | tert-butyl hydroperoxide | increases expression | EXP | | 6480464 | tert-Butylhydroperoxide results in increased expression of MIA2 mRNA | CTD | PMID:12414654 | MIA2 | Human | thioacetamide | decreases expression | ISO | Mia2 (Rattus norvegicus) | 6480464 | Thioacetamide results in decreased expression of MIA2 mRNA | CTD | PMID:34492290 | MIA2 | Human | topotecan | multiple interactions | ISO | Mia2 (Rattus norvegicus) | 6480464 | [Oxaliplatin co-treated with Topotecan] results in decreased expression of MIA2 mRNA | CTD | PMID:25729387 | MIA2 | Human | trichloroethene | increases methylation | ISO | Mia2 (Rattus norvegicus) | 6480464 | Trichloroethylene results in increased methylation of MIA2 gene | CTD | PMID:27618143 | MIA2 | Human | trichloroethene | increases expression | ISO | Mia2 (Rattus norvegicus) | 6480464 | Trichloroethylene results in increased expression of MIA2 mRNA | CTD | PMID:33387578 | MIA2 | Human | trichostatin A | increases expression | EXP | | 6480464 | trichostatin A results in increased expression of MIA2 mRNA | CTD | PMID:24935251 | MIA2 | Human | triptonide | increases expression | ISO | Mia2 (Mus musculus) | 6480464 | triptonide results in increased expression of MIA2 mRNA | CTD | PMID:33045310 | MIA2 | Human | valdecoxib | decreases expression | ISO | Mia2 (Rattus norvegicus) | 6480464 | valdecoxib results in decreased expression of MIA2 mRNA | CTD | PMID:24136188 | MIA2 | Human | valproic acid | decreases expression | EXP | | 6480464 | Valproic Acid results in decreased expression of MIA2 mRNA | CTD | PMID:29154799 | MIA2 | Human | vinclozolin | affects expression | ISO | Mia2 (Rattus norvegicus) | 6480464 | vinclozolin affects the expression of MIA2 mRNA | CTD | PMID:19015723 | MIA2 | Human | vinclozolin | increases expression | ISO | Mia2 (Rattus norvegicus) | 6480464 | vinclozolin results in increased expression of MIA2 mRNA | CTD | PMID:22570695 | MIA2 | Human | zinc atom | increases expression | EXP | | 6480464 | Zinc deficiency results in increased expression of MIA2 mRNA | CTD | PMID:18356318 | MIA2 | Human | zinc(0) | increases expression | EXP | | 6480464 | Zinc deficiency results in increased expression of MIA2 mRNA | CTD | PMID:18356318 | |